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ABSTRACT 
We investigated the clfcet of admlnisu,lIion of somatotropin (ST) and/or cCG on insul io ·like growth faClo r I (IGF·I) and IGF· 
binding prou:ills ( IGFBP) '0 serum and fo llicular Huid (I'I'L) of caule aClive 'y immunizc:d agail'lSt growth ho rmone·releasing faclor 
(GRf). Cyelic beef canle, p reviously immuni~ed agahl!il GRF{ 1-29}Gly·Gly·Cys·NH, conjugliled to human serum albumin (syn· 
thesized and provided by tlotrmano·LaRocbc, Inc., Nutley. /'10; GRfi. n "" 31) o r to human serum albumin alone ( HSAi, n '" 26), 
received (Lm.): I) 25 mg rccombinm tly deri\'ed mcthiooyl somatouopln (rbST, II = 14; somelribove provided by Monsanto 
Co., St. Louis, MO); 2) 1100 IU c:CG ( n '" 10), 3) rbST and cCG (rbST-d:G, n = 15); or 4) "chide (VEH, n "" 17) at 0 and 24 
b after receiving pl'O!'ilagiandln 1'... (PGFloo ). Saum samples were: COllected at 0 and 40 h after PGF ... , and me: ovary bearing me: 
largest foUide (ooM) was n;moved 44.0 :t: 0 .5 h alter PGF ... , FFL _ h1l'VC$tcd from 00-'1 and the subordioate foUiele (SUB). 
Ikfore: treatment (0 h). GRFi <:ows h3d lowff serum ST (0.6 ;t; 0.2 V$. 2.2 ;t; 0 .2 ng/ ml; p < 0,01 ) and IGF·I (26 :t: 4 V$. 72 ;t; 
4 ng/mJ;p < 0,01). but gte ller IGFBP·2 (594 :t: 48 V$. 384 ;t; 52 ng/ml,p < O.oJ) m;an HSAi cows. Sc:rum and FFL concentrations 
of IGI'·J or IGfBp·2 were: 00( different bc;",,'ec:n rbST· and rbST<CG·tr(:alcd cows or bc:twcc:n VEH- and cCG·trcatcd cows at 
Hour 40 aftC1' the io itial tte2tmc:n t inje<:tlon; therefore::. data were combined and designated as rbST and VEH. rc:spc:cti..cly. Serum 
IGF·I ~'3.S increased to a greater ex tent (pcrceotagc: incrca.\C: above: 0 h ) by rhST treatment in GRFI (362 ;t; 24) tlwi in HSAI 
( 176:t: 16) cows (immuni7,a tion by UU lmCllt,p < 0.01). Across GRFi ;and HSAi, rbST lowc:tt.'d serum IGFBP·2 (342:t: 31 vs. 
54 1 ± 27 ng/ml, rbST V5. VEil: p < 0.0 1)_ Di;uneters of DOM or SUB were no t aJJccted by lmmunlutlon o r treatment. Con· 
centrations of IGF·' and IGFBP·3 (dctt'1Tl1incd by ligand blot aoalysis ) in FFL from both DOM and SUB wen: lower (p < 0.05) 
In GRFi than in HSAJ CQW5. In contrast , IGFBP·2 in W I. was clev.ucd in SUB, but not DOM, in GRf'i compared to HSAl {'()ws. 
IJgand blot anal)'SCll inlliatctl that IGfBP·4 and IGFBP·5 were:: markedly h igher in FFL from SUB in GRfi thm in HSAi cows, but 
nOt different for ooM. Administration of rbS'l' iocrcascd IGF·' and dc:crca$cd IGFBp·2 in OOM and SUB. In conclusion, GRFI 
dc:crc:tSed serum and FFL concentn tions of IGF·', ... ·hLle il iocrC1SCd concentrations of IGFBP·2 In serum and in FfL from SUB. 
but IIOt ooM. Trc:ttment wi th rbST increased serum and FFL IGF·I, but dc:crc:ascd both serum and FFL IGmp·2 (in both DO!>! 
and SUB). lhc specific rold that IGF· I and IGFBP pia)' io (olliculogcnesl5 arc yet 10 be: determined; of particUlar interC5t15 the 
divergent dfcct 01 GRFi on IGFBP in dominant \ '5. 5uboc'dirulte folli cles. 
INmQDUCTlON 	 progesterone (P4) and oxytocin to values greater than those 
obtained with FSH alone in bovine granulosa cells. Fur­SomatotrOpin (ST) is a key regulator of somatic growth. 
thermore, gonadolropins increase IGF-I secretion by por­In ruminants, hypophysectomy [1] or active immunization 
cine granulosa cells (1l). IGFBP have been shown to inhibit againSt growth hormone-releasing factor (GRF) (2-4] de­
stero id production by granulosa cells in vitro [12J and to creases bod)' weighl gain and skelelal growth, while treat· 
inhibit ovulatio n in vivo [ 131. These observations support a ment with exogenous ST enhances deposition of lean tissue 
possible role for ST, IGF-I, and/or TGffiP in the regulation 15]. A portion of the effectS of ST are mediated by insulin­
o f ovarian funaio n, specifically foll iculogenesis.like growth factors ( IGF). TIle IGF circulate bound to spe­
In Ihe presence of insulin, ST has been shown to en­cific binding prOteins (lGFBP), which modulate their func· 
hance cell growth in OOvine in vitro<ullured granulosa cells tion [6]. [14J and p. produaio n in bovine [14] and porcine [15] inIn vitro studies have shown that IGF-I enhances FSH· 
vitro-cultured granulosa cells. Jia et al. [16J have demon­slimulated steroid productio n in murine [7J and porcine 
strated that ST augments gonadotropin-stimulated differ­granulosa cells [8,9]. Schams [10J has shown that IGF·I in­
entiation or in vitro-cultured granu losa cells obtained from 
creases, in a dose-<tependent manner, the production of immature ratS. In vivo effects of ST on ovarian function have 
Ix!cn studied in cattle (4, 17-21] and prepubertal gi lts (22­
Aaqlttd Septcni:>er 20. 1993. 2S], but the results have been variable. Active immunization 
RettMd february 17, 1993. 
against GRF has been shown to decrease serum Sf and IGF­
'1Iac:an;h reponed 10 this publication ..... ~ by the North C:uolina AIlS 
and Competitive ~ Gr:mtS O!fItt/llSDA (#90-J7240-5511). ",., ~ of l.-ado: I and to dela), puberty in beef heifers [3,4 ). Heifers im­
names in this publicalion doe$ noo: Impl)' er>dol~mem by the North carolina AIlS munized against GRF that failed 10 reach puberty by 18.5 
nor crkklsrn of similar produos noo: mentioned. mo of age had lower serum IGF-I concemrations at the time 
'Correspondeocc: (lef:wtrrll:m of AnlrruJ SCience, Norlh. ~rol;na ~e Unlver· 
slty. ao~ 762t. IQleigh, NC 27~762 t . FAX' (919) ~1S-7780. of primary GRF immunizatio n (6 mo of age). We admin­
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istered ST and/or eCG (0 beef cows that had been previ­
ously immunized against GRF to clarify (he interactions be­
tween ST, IGF-J, IGFBP, and gonadotropins at the level of 
the ovary. Specifically, our objective was 10 quantify IGF-I 
and IGFBP in fo llicular fluid (FA..) from cyclic cows with 
e levated, normal, or low serum ST and IGF-I. 
MATERIALS AND METHODS 
Cyclic nulliparous and primiparous Angus and Charolais 
(n = 43) [3,26] or multiparous Angus and Hereford (n '"" 
12) females [27J, previously immunized. against GRF or hu­
man serum albumin, were used. The 2- to 3-yr-old Angus 
and CharoJais cows weighed 407 ± 11 and 440 ± 14 kg, 
respeaively. The multiparous Angus and Hereford cows were 
5-6 yr of age and weighed 475 ± 31 kg. Cows were im­
munized with 1.5 mg GRF-(1-29)-Gly-Gly-Cys·NHz conju­
gated to 1.5 mg human serum albumin (GRFi j Hoffmann 
La-Roche, Inc., Nutley, NJ) or with 1.5 mg human serum 
albumin (HSAij Sigma Chemical Co., 5t. Louis, MO) at 6 mo 
of age [3,26] or at 3-4 yr of age [27J. Cows were admin­
istered booster immunizatio ns as p revio usly described 
[3, 26, 27J; however, the most recent booster immunization 
\\-"Quld have been given at least 3 mo before initiation of 
this study. A final booster injection was given 4 wk before 
the study began. 
Estrous cycles were synchronized by three i.m. injec­
tions of prostaglandin F:z.:, (PGF2cJj Lutalyse, Upjohn, Kala­
mazoo, MI) given 14 days apan ( 1000-1400 h). Prior to 
synchronization, cows were maintained on grass-legume 
pasture. At the time of the fi rst PGF:z.:, injection, cows were 
moved to open-sided pens with sloned floors (30 m X 9 
m). CO"ws were fed a diet of sorghum silage and concen­
trate calculated to proVide 100% of NRC recommendations 
[28J for a 5OQ.-kg mature, nonlactating beef cow. Cows were 
divided randomly within breed (Angus, Charolais, or Here­
ford) and immunization status (GRFi, n "" 31,398 ± 18 kg; 
or HSAi, n == 26, 443 ± 9 kg) into one of four treatment 
groups: 1) rbST: i.m. injection (25 mg) of rbST (sometri­
bove; Monsanto Co., 51. Louis, MO) (GRFi-rbST, n "" 10; 
HSAi-rbST, n = 4); 2) eCG: i.m. injeaion ( 1100 IV) of eCG 
(Diosynth Inc., Chicago, IL) (GRFi-eCG, n == 5; HSAi-eCG, 
n = 6); 3) rbST-eCG: i.m. injeaio ns of rbST (25 mg) and 
eCG ( 1100 IU) (GRFi-rbST-eCG, n = 6; HSAi-rbST-eCG, n 
= 9): or 4) VEH: i.m. injection (2.5 ml) of sterile 35 mM 
NaHCO, (Sigma) (GRFi-VEH, n "" 10; H5Ai-VEH, n == 7). 
We ensured that 4-6 cows were in each creatment; excess 
animals were allocated to rbST and VEH treatments. The 
dosage of eCG specified above was used to achieve follic­
ular stimulation without superovulatio n [291. Cows received 
the ir respective treatments at 0 and 24 h from the last in­
jectio n o f PGF:z.:,. Procedures were approved by the North 
Carolina State University Animal Care and Use Comminee. 
Approximately 44.0 (± 0.5) h after the last injection of 
PGF20, ovaries were examined via the rectum by real-time 
ultrasound (Aloka 500V; Corometrics Medical Systems, Inc., 
Wallingford, CT) using a 7.5-MHz transducer (Aioka, UST· 
660-7.5; CorOmetrics). Time after PGF2cJ was based on a 
preliminary experiment in which ovaries were removed at 
24 or 48 h after PGF2cJ administration. Epidural anesthesia 
was produced by infiltrating the epidural space between 
the last sacral and first caudal vertebrae with 5 ml of 2% 
lidocaine HCI (Lidocaine; Sigma-Aldrich Corp., Milwaukee, 
WI). Once identified, the ovary bearing the largest follicle 
was unilaterally removed by inserting an ecraseur through 
an incis io n in the dorsal wall of the vagina. Cows thai had 
ovulated were excluded. Ovaries were placed on ice and 
transported to the IaOOratory. Diameters of the largest (OOM) 
and subordinate fo llicle (SUB), on the single ovary re­
moved, were recorded; DOM was dissected free of ovarian 
stroma, and ffi was aspirated from OOM and SUB. FFl. was 
centrifuged at 1500 x g for 15 min to remove cellular de· 
bris and then aspiraced and stored at - 2ifC until analyzed 
fo r IGF-I and IGFBP. All steps were completed within 30 
min of ovarieaomy. 
Blood samples were collected via jugular or coccygeal 
venipuncture three times per week during estrous syn­
ch ronization to monitor P4 concentrations. Single blood 
samples were also collecr:ed before initiation of treaunem 
(0 h) and before ovariectomy (40 h). Blood samples were 
stored at 4°C for at least 8 h and centrifuged at 1500 x g 
for 30 min; serum was stored at - 20°C until analyzed for 
ST, IGF-I, and IGFBP. 
A5says 
Serum concentrations of P4 were determined using P4 
(P-OI30, Sigma) standards prepared in om M PBS-O.1% gel­
atin (G8-500; Fisher Scientific, Atlanta, GA) by a solid-phase 
RIA (Diagnostic Products Corp., Los Angeles, CA). Average 
intra· and imerassay coefficients of variatio n (CV) were 6.6 
and 10.1%, respectively, for five assays. Sensitivity, defined 
as 90% of total binding, was 0.5 ng/mi. 
Serum concentrations of ST were determined in a single 
assay by the procedure described by Armstrong and Spears 
[30]. Intraassay CV and sensitiVity, as described previously, 
were 9.6% and 0.6 ng/ml, respectively. Serum and FFL con· 
centrations of IGF-I were determined as described by 
Houseknecht ct al. [31J with modifications [32,33]. Addition 
of 0.5, 1, and 4 ng of IGF-l (before extraction) to FA. yielded 
recoveries of 79, 81, and 83%. Assay of 5, 10, 20, and 40 ~ 
of serum and FA. resulted in a line parallel to that for known 
concentrations of IGF-I . Average intra- and interassay CVs 
were 8.3 and 10.2%, respectively, for four assays. Assay sen· 
sitivity, as described previously, was 6.2 ng/ml. 
Concentrations of IGFBP-2 in serum and FFL were de­
term ined by double-amitxxiy RIA as detailed by Cohick el 
al. 134]. Bovine IGFBp·2 was purified from Madin-Darby bo­
vine kidney cell-conditioned medium and used for iodi­
nation, standards, and generalio n of specific IGFBP-2 anti­
sera. Serum and FFL samples were diluted 1 :20 with RIA 
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FIG. 1. Concentrations of ST (mean % SEM) al 0 lind 40 II after treat_ 
ment wilh rbST, eCG, rb$T .nd eCG IrbST -eCG). 0. vehicle in cyclic cow. 
previously immunized .gainst GRF·{1-29)·Gly-Gly-Cys-NHr humlU'l ..rum 
all)l.lmio (GRFI, n '" 26) 0.. human serum albumin (HSAi, n - 24). T ...,­
ments were .dmil'liitered li.m.' III 0 and 24 h ' rom injection of PGf... Con­
centrations of ST we•• similar in rbST lind rb$T.eCG cows; Ih u$ data were 
combined and presented ., rbST In '" 251. ST W8I liso similar in vehicle­
lind eCG-treated COWl and lUll. were combined 'Of presentalion (presented 
IS VEH, n '" 251. The lreatmenl-by-immunllatlol'l interaction was not 'ig­
ni'ie.nl. Serum ST wu lower (p < 0.01) in GRFI thin in HSAi cows at Hour 
0, but nol lil Hour 40. Concentrations of ST we•• increased (p < 0.01) 111 
40 II . fte r rbST t.lltmenl. 
buffer, and 5 ~I was analyzed. The sensitivi ty of the assay 
was 0.6 ng/ml. Average intra- and interassay OIs were 6.7 
and 8.9%, respectively, for two assays. 
ligand and ImmunoblOlling 
Serum and FR. IGFBP from individual GRFi or HSAi COWS 
treated with VEH were visualized by ligand blotting. Pro­
cedures were carried out as described by Hossenlopp et 
al. (35J with modifications as follows: aliquOts of serum and 
FFL (10 ~I) were mixed with 130 ~l of sample buffer (sin· 
gle-strength), and 14 ~I of diluted sample was loaded onto 
12.5% discontinuous SOS-polyacrylamide gels. Gel electro­
phoresis was perfo rmed with a Mighty Small II Appararus 
(Hoeffer Scientific Instruments, San Francisco, CA) a! 25 rnA 
per gel until the dye front reached the bottom of the gel. 
Proteins were then transferred to polyvinyldifluo ride (PVOF) 
filters (lmmobilon P; 0.45·~m pore size; Millipore Co., Bed­
ford, MA) with a semi..cfry electroblooer Oanssen Ufe Sci­
ences ProduCtS, Piscataway, NJ) at 70 rnA for 75 min. The 
filters were probed overnight with [1~1 JIGF-I, washed, and 
audioradiographed by exposure to Kodak X-Omat AR film 
(Eastman Kodak Co., Rochester, NY). Molecular weight es­
timates were based on preslained protein standards (Ame r­
sham Corp., Arlington Heights, IL). Band intensities were 
determined by use of the Hoeffer 350 program and den­
sito meter. 
To identify specific fOrolS of IGFBPs, immunoblouing of 
the filters was performed with antibodies against bovine 
IGFBP-2 and -3 (34J and human IGFBP-5 (361. Primary an­
tibodies were diluted in TBS (200 mM NaCI, 50 mM Tris, 
40hTime 
pH 7.4) containing 1% BSA and used at dilutions of 1:2000 
(IGFBP-2) and 1:1000 (lGFBP-3 and -5). The filters were 
rinsed for 15 mi n in rns containing 5% Tween-20, blocked 
for 15 min (lGFBP-2 and -3) or 2 h (IGFBP-5) with rns 
containing 3% BSA, and incubated overnight at room tem­
perature with the primary antibody. The filters probed with 
IGFBP-2 o r -3 antisera were washed with TBS containing 
0.1% NP-40 and 0.03% Triton X- loo (three times for 10 min 
each) and then incubated for 3 h with alkaline phosphatase­
conjugated second antibody (Sigma). After washing with TBS 
containing 0.1 % NP--40 and 0.03% Trito n X-JOO (three times 
for 10 min each), alkaline phosphatase aaivity was detected 
via the Problot immunoblotting system (Promega, Madison, 
WI). After the primary antibody incubations, the filters probed 
with IGFBP·5 antisera were W'.l5hed in TBS containing 0.1% 
Tween-20 (twice for 15 min each), then washed for IS min 
in TBS containing 1.0% Tween-20, and again washed in TBS 
COntaining 0.1% Tween-20 ( twice for 15 min each); they 
were incubated for 3 h with peroxidasc<onjugated ami­
guinea pig IgC (Sigma). The washes in TBS containing 
Tween-20 were repeated as described above, and peroxi­
dase aaivity was detected by means of the Eo.. chernilu­
minescent detection system (Amersham). 
Sta/isJical Analyses 
All analyses were conduaed by means of GLM proce· 
dures (371. Ho rmone data from serum colleaed at 0 and 
40 h were analyzed using a model containing immunization 
(GRFi vs. HSAi), treatment (VEH, rbST, ECG, rbST-ECG), 
immunization by treatment, cow within immunization by 
treatment, hour, immunization by hour, treatment by hour, 
and immunization by treatment by hour. The effects of im­
munization, treatment, and immunization by treatment \\'ere 
tested using cow within immunization by treatment mean 
square as the error term. Initial analyses revealed that nei­
ther breed nor imeracrions involving breed were signifi· 
cant; thus effects involving breed were o mitted from sub­
sequent analyses. Due to the pretre-dtmem diffe rence in 
serum IGF-I be(Ween GRFi and HSAi, serum IGF-I concen­
trations at 40 h were expressed as percentage of pretreat­
ment serum IGF-L Treatment means were compared by 
Student Newman-Keuls test using cow within immunization 
by treatment as the error term. 
Hormone concentrations from FFl.. (lGF-I and IGFBP-2) 
were analyzed through use of a model containing immu­
nization, treatment, and immun ization by treatment. Initial 
analyses revealed that neither breed nor interactions in· 
volving breed were significant; thus effectS involving breed 
were omitted from subsequent analyses. Diameter, diam­
eter by treatment, and diameter by immuni7..ation were In­
cluded as covariatesj covaoates not contributing to varia­
lion (p > 0.1) were deleted from subsequent analyses. 
Treatment means were compared by Student Newman-Keuls 
test for ST, IGF-I, and IGFBP-2. A separate analysis was con­
duaed to dete rmine the effect of source (OOM, SUB, or 
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FIG. 2. Sel"\lm concentration. of IGF-l (mean j: SEM) at 0 and 40 h 
after treatment with rbST, eCG, rbST and eCG. or vehicle in cyclic COW$ 
previously immunlled against GRF·( I -29j·GIy·Gly·Cys-NH r human serum 
albumin (GRA, 1'1 .. 26) or human serum albumin (HSAi, 1'1 .. :z.t). Treer· 
ments were admin istered Ii-m.) at 0 ,nd 24 h from IIdmil'listl1ltion of PGF",. 
Concentrations of IGF·I were similar il'l rbST 'nd rbST-eCG cows; thu. date 
were combined end presented eI rbST (n .. 25). Serum IGF-l Wei also sim· 
liar in vehicle- Il'Id eCG·lrealed COWl and data werl combined for presen­
tation ilt VEH, n .. 251. Serum IGF-I WI' greater (p < 0.01) in HSAi than 
in GRA at 0 h. AI 40 h, rbST inc ....sed serum IGf..! to a simila r level in 
GRFi and HSAi cows. 
serum) on concentraLions of IGFBP·2. The model used for 
analys is was s imilar to the model used for serum hormone 
analyses, with hour replaced by source. Pearson correlation 
coeffiCients were C'J,Jculated across treaunent and immuni­
zation groups between follicular diameter and FFl concen· 
trations of IGF-I or IGFBP-2. Band intensities of IGFBP other 
than IGFBP-2 were analyzed by independent I·test. 
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FIG. 3. Serum concentration, of IGFBp·2 (lelft-Squares mean =SEM) 
It 0 Il'Id 40 h after treatment with rbST, eGG, rbST al'ld eCG. or vehicle in 
cyclic COWl previoully immunized ag.lnst GRF-{1-29)·Gly·Gly·Cy.·NHl ·hu· 
m.n serum albumil'l {GRA, n .. 26) or human serum albumin {HSAi, 1'1 .. 
241. Treatmll'lt$ were administered U.m.) at 0 .nd 24 h from PGFa.,. Serum 
lGFBp·2 Wit similar In rbST- and rbST·eCG·ltelted cows; thus dill were 
combined Ind presented al rbST (n ... 25). COncentrations of serum IGFBP· 
2 were a lso similar in vehicle-and ICG·t reated COW$ and dala were com· 
blned {presented II VEH, 1'1 .. 25). The treatmant·by·immul'lilltIOl'l inter· 
action was l'Iot .ignifiClint. Serum IGFBP-2 wal grel ler I p < 0 .01) il'l GRFi 
thin 11'1 HSAi cows It Hour 0, but not II Hour 40. Aeross immunization, 
concentrations of "rum lGFBp·2 were lower Ip < 0.01) in rbST than in 
VEH COW$. 
TABLE 1. Mean diameter {mm) of the largest {ooM)lnd second larg"t 
lorticles (SUB) removed 44 h Ifter injectiol'l of PGFz" from cyclic 00_ 
immunized agllnlt GR F" or HSA- and adminlSlered rbST, rbST ..cG, etG, 
or vehicle. 
Immunization 
GRFiTreetmlnt" HSAI 
DOM 
rbST 15.5 :t. 1.1" 15.3 j: 2.0 
rbST·PMSG 11.0:t. 1.6 15.6 j: 1.9 
PMSG 13.6 :t. 2.1 11.0 j: 3.0 
VEH 15.1 :t. 0.8 18.6 j: 2.2 
SUB 
rt>ST 9.8 :t. 2.4 1.3 :t. 1.2 
rbST·PMSG 10.6 ;!:: 1.4 10.8 j: 1.6 
PMSG 8.8 ;!:: 1.5 6.2 =1.6 
VEH 9.1 ... 1.1 SA ;!:: 1.0 
°GRF.I1·29I-GLY·GLY-CVS·NHJ conjugated to human serum albumin IGRFi). 

~umal'l serum albumin {HSAiJ. 

erreatments were administered Ii.m.) II 0 and 24 h after injection of PGF... 

"Mean =SEM. 
RESULTS 
Seven cows ovulated before ovariectomy and were de­
leted from the smdy. Cows mat had ovulated were distrib­
uted evenly across immunization and treatment groups. 
Differences were not deteaed (p > 0.1) ber;veen rbST 
and rbST -eCG treatments in any of the serum or R'1.. vari· 
abies measured; therefore, these treatments were com­
bined for presemation (represented by rbST). The effect of 
treatment with eCG was similar (p > 0.1) to that of VEH 
0 HSAI·VEH 
- ~ HSAi-rbSTE
-D> GRA-VEHS •III GRA·tbST 
"­!2 
~ 
m 
"5 
.2 
'5 
u.. 
IJCM 51.11Follicle 
AG. " Mean j;!:: SEM) conoentration. of IGF-! in the IIIVMt 100M) and 
second largestlSUB) foll icle. II II h after treatment with rbST, eCG, rbST 
and ECG, or vehicle in cyclic cows prevlou.ly Immunized against GRF-{I-
291·Gly·Gly-CY'·NHr human lerum albumin IGRFi, n ... 261 or humIn serum 
albumin (HSAi, n .. 24) . TnNtments were administered ILm.11I 0 and 24 
h from injection of PGF... All COWl were unilaterally ovariectomized II II 
h. FFl concentrations of IGF·I were 'imil" in rbST Ind rbST-etG cows; 
thul date werl combined and presented U rbST In ... 251. Similarly, IGf..! 
wu not dilferel'lt in vehicle· .nd etG·treated COWl a/lel data were com· 
blned (presented as VEH. 1'1 .. 25). Concentrations of IGF·I il'l ooM and SUB 
were lower (p < O.OS) in GRFi th." in HSAi cows. Aeron lmmunizltiol'l, 
Ireatmetlt with tbST increased (p < 0.01 .nd p < 0.01, rnpectiv&lv)IGF-l 
In ooM and SUB. The treatmlnl·by·immunizllion inter.etion was not .Ig· 
l'IirlCant. 
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FlG. 5. Identification of the IGFBP present in FFL FFL Irom ,he second largHt follicle of an indi...iduill cow im­
munized against GRF and treated with vehicle was subjected to 50S·PAGE under I'IOl'Ireducing conditions. The SlIme 
SIImpla was F\lI'I in multiple lanes 12 ILl per lime) on III I;ngl, geL. After transfer 10 • PVOF filter, the lanes were cut 
apart and probed with 112'1j1GF_1 Uane 2) 0' with antibodies ag.inst bovine IGFBP-3 !Iene 3), bovine IGFBP-2 (I.ne 4), 
and hum," fG FBP-5 (lane 5) as described in Mat~i.ls lind Melhods. Lane I represents serum (2 IllI obtained from 
Ihi, tow.l 44 h lifter injeclion 01 vehicle, which was run on the ume gel and probed Wilh IUIoIIIGf_1. Molecular weigh t 
st.nderds were run in III par'lIel lane. 
for all honnones anaJyt.ed. Therefore these U'eaunems were 
combined for presentation (represented as VEH). 
Mean concentrations of serum ST at 0 h were lower (p 
< 0.01) in GRFi (0.6 ± 0.2 ng/ml) than in HSAi (2.2 ± 0.2 
ng/ml) cows (Fig. 1). However, 40 h after initiation oftreat­
ments, serum ST was similar (p > 0.1) in GRFi (10.0 ± 0.8 
ng/ml) and HSAi (10.6 ± 0.8 ng/ml) cows (Fig. 1). Across 
immuni7.ation group, concentrations of ST were greater (p 
< 0.05) in serum from cows receiving rbST than in serum 
of cows receiving VEH (18.5 ± 1.2 vs. 2.0 ± 1.1 nglm l, 
respeaivelYi Fig. I ). The ueatment-by-immunization inter­
aaion was IlOI Significant (p > 0.1). Both treatment by hour 
and immunization by hour affected (p < Om) serum ST 
concentrations. 
Average serum concentrations of IGF-I at 0 and 40 h from 
initiation of treatments in GRFi and HSAi cows are depiaed 
in Figure 2. Concentrations (ng/ml) of IGF-I were lower 
(p < 0.01) in GRFi (26.0 ± 4.0) than in HSAi (69.0 ± 5.0) 
cows at 0 h (Fig. 2). Serum IGF-I expressed as a percentage 
of respeaive O-h concentrations was greater (p < 0.05) fo l­
lowing rbST (269 ± J5) than fo llowing VEH (94 ± IS)i this 
value was also greate r in GRFi (362 ± 24) than in HSAi 
(176 ± 16) cows receiving rbST ( immunization by treat­
mem,p < 0.01). Adual increases in serum fGF-t after rbST 
were 56 ± 11 nglml vs. 44 ± 11 nglml for GRFi and HSAi, 
respectivelYi and tOlal concentrations at 40 h were not sig­
nifkantly different (54 ± 7 nglml vs. 88 ± 8 ng/ml, re­
spectively, p > 0.1). TIle interaction'> of tre'.umem by hour 
and immunization by hour contributed (p < 0.01) to vari­
ation in serum IGF-1. 
Before treaunem, serum concentrations of fGFBP-2 were 
significantly greater in GRFi than in HSAi cows (594 ± 48 
vs. 384 ± 52 ng/ml, respectivelYi Fig. 3). After treatment 
with rbST, serum IGFBP-2 was decreased in both GRFi (371 
± 34 ng/ml) and HSAi (314 ± 27) cows (Fig. 3). Immu­
nization by treatment was not s ignificant (p > 0.1); how­
ever, both treatment by hour (p < 0.05) and immunization 
by hour (p < 0.01) contributed to variation in serum IGFBP­
2. 
Diameters of DOM or SUB were nOt affected (p > 0. 1) 
by immunization or treaunent (Table 1). As expected, mean 
diameler of DOM was greater (p < 0.05) than that of SUB. 
Concentrations of IGF-I in FFl. collected from GRFi or 
HSAi cows 44 ± 0.5 h after initiation of treaunent are pre­
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FIG. 6. Forms of IGFBP pres~lnt in FFL from indiyidual largest (panel A end 8) or second 1~lrgeSl (pinel C) follieles 
from cows immunized .".inll GRF-I1-29)-Gly·Gly·Cys·NH.-human "rom albumin IGRFi) or human sel'\lm albumin 
IHSAi) and trealed with vehicle only. Vehicle Wilt administered li.m.) et 0 ,nd 24 h after PGf... All eows were unj· 
I.t"ally oYariedomized " 44 h. Serum from a ajogla HSAi-vehicle-lreated cow ~lnd from a bovine 581'um pool were 
included for comparison (panel A and 8 ). Sampkt, were l ubjected to 50S·PAGE under non reducing eol'ld itlons, Il1Ins­
ferred 10 PVDF fitlera. and Pfobed with I' ''IHGF-III described in Maler;,I, and Methods. Molec\ller weight standards 
were nil'! in a parallel I,ne. 
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AG. 1. FFl concentrations of fG FBP-2 (lu'l-squares mean l: SEI in 
the largest lOOM) and second largest (SUB) fOlliele. 8t 44 h after treatment 
with rbST. eCG, rbST and eCG, or vehitl, In eyelie cows previously im­
munized IIgllinlt QRF-II-29).(ily-GIy-Cys-NHyhum.n serum albumin !GRF). 
n .. 26) or human serum .Ibumin /HSAi, n .. 241. Treatments _" ad. 
ministered (i,m.1 at 0 and z.t h aft., prollegtandin F .... All cows were UI'I;' 
laler.tty ovariectomized at 44 h. FFl contentralions oIIGFBP-2 ....erll .imilar 
in rbST and rbST -eCG·tntated cows; thul dtll wele combined and Itl pre­
Hoted 85 rbST In .. 251. Similarly. IGFBP·2 W8I similar in vehicle- Il'Id etG­
Ireeted cows and da" were eombin&d for presentation (as VEH, n .. 251. 
Foiliculal IGfBP· 2 w.. g"'ler (p < 0.051 in GR F) Ihan in HSAI cows In 
SUB. but not in DaM. Concentrations of follicular IGFBP-2 from OOM .nd 
SUB were lower (p < 0.05) in rbST- 11'181'1 in ViH-tre.ted COWl. The I~.t· 
ment·by·immuniletion interaction wes 1'101 lignlne.l'1I. 
sented in Figure 4. FR concentrations of IGF-I (ng/ml) in 
OOM and SUB were lower (p < 0.05) in GRFi (88.6 ± 8 
and 108 ± 11 , respeaively) man in HSAi (107 ± 6 and 127 
± 8, respeaively) cows (Fig. 4). Regardless of immuniza­
tion statuS, treatment (ruST vs. VEH) increased IGF-I (ngl 
ml) in OOM. ( 110 ± II \'5. 85 ± 9) and in SUB ( 134 ± 13 
vs. 98 ± 12; Fig. 4, P < 0.0 1). The immunization-by-treat­
ment interaction did not contribute (p > 0.1) to variation 
in FA.. IGF-1. Fo llicular concentrations of IGF-I and fo llic­
ular diameter were not correlated in eimer OOM (r = -0.26; 
p = 0.07) or SUB (r = O.08;p > 0.6). However, serum IGF· 
I was correlated (p < 0.01) with FFL IGF·I in both OOM. 
(r = 0.64) and SUB (r = 0.44). Across treaunent and fol­
licle, FA.. IGF·I was correlated (p < 0.05) with fo llicu lar 
diameter (r = - 0.24). 
Ligand blot analysis of ffi and serum revealed multiple 
bands mat round [12SIIIGF_I (Fig. 6). ImmunoblQl analyses 
with specific antibodies against IGH~Ps identified the 43 000 
and 39 (XX) M. bands as IGFBP·3; the 34 (XX) M. band as IGFBP­
2; and a 31 000-32 000 M, doublet as IGFBP·S (Fig. 5). The 
additional band at Mr 24000 is likely to be IGFBP-4, bUI nO 
immunoblot was conducted to verify this. ImmunoblOI 
analysis also indicated that ffi from roth DOM and SUB 
contained two non-IGF binding IGFBP-2 fragments with ap­
proximate molecular weights of 22000 and 14000. Small 
amounts of IGFBP'5 fragmen! (apprOXimately 21000 Mr) 
were also detectable in some samples. The relative inten­
sities of the IGFBP·2, -5, and -4 bands prescm in FA. from 
ooMwere not differem between GRn and HSAi cows (Fig. 
SUI 
6, panels A and B), and considerable variation was ob­
served betwc..-en animals. However, with me exception of 
band imensities for one cow from each group, the imen· 
slUes of the IGFBP·2, '5, and 4 bands were markedly grealer 
in FA. from SUB of GRFi compared to HSAi anilT).11s (Fig. 
6, panel C). In contrast, me band intensities of IGFBP-3 de­
termined by scanning densitometry were lower for GRFi 
compared to HSAi animals with respect to FA.. from both 
OOM ( 12606 ± 2665 vs. 21 107 ± 2909;p < 0.05) and SUB 
(18485 ± 316 " . 28658 ± 2793, p < 0.05). 
Quantitation of IGFBP-2 by RIA indicated that adivc im­
munization against GRF increased (p < 0.05) IGFBP-2 (ngl 
ml) in FA. fro m SUB (664 ± 51 vs. 512 ± 51) but not (p 
> 0.1) from DOM (549 ± 29 vs. 482 ± 29; Fig. 7). Follicular 
IGFBP-2 (ng/ml) concentmtions were decreased in roth 
DOM (465 ± 38 vs. 560 ± 44) and SUB (536 ± 66 vs. 666 
± 66, P < 0.05) by rbST treatment. The immunization-by­
treatment interaaion was not significant (p > 0.1) for m 
IGFBP-2 in OOM or SUB. Follicular IGFBP-2 concentr'Jlion 
and diameter were inversely related (p < 0.05) in both 
DOM (r "" -0.35) and SUB (r = - 0.31). Mo reover, across 
treatment and follicle, FA.. IGFBP-2 concentration and di­
ameter were also negatively correlated (p < 0.01; r = -0.(0). 
Serum concentration of IGFBP-2 was corre lated (p < 0.01) 
wim ffi IGFBP-2 o nly in DOM (r = 0.57). However, FA. 
IGF·! and FA.. IGFBP-2 concentrations were not related (p 
> 0.2) in e ither DOM (r = - 0.18) o r SUB (r "" -:- 0.17). 
Source (OOM, SUB, or serum) contributed (p < 0.01) to 
variation in concentrations of IGFBP-2; however, source did 
flO( interact (p > 0.2) wilh treatment or immuni7..ation. Across 
treatment and immunization, concentrations of IGFBP-2 (ng! 
011) were greater (p < 0.05) in SUB (599 ± 81) than in 
DOM (510 ± 58); this finding was similar to [hat for !GFBP~ 
2 in serum (452 ± 38). 
DISCUSSION 
ACtive immunization against GRF provides an effective 
means to uncouple GRF and ST [4 ~ Immunoncutralization 
of GRF abolishes episodiC release of ST and suppresses 
serum ST and lGF-I in cyclic gilts [38), lactating sows [391, 
lactating cows [271, growing steers [2,40}, and he ifers [3]. 
Administration of I:xJoster immuni7..ations to GRFi cows 
maintained suppressed serum ST and JGF-I throughout the 
experiment (Fig. 1 and 2). 
In the present study, administration of rbST incre-ASed 
serum ST arove physiological levels at 40 h after initiation 
of treatment in cows with no rmal (HSAi) o r suppressed 
(GRFi) ST (Fig. 1). As would be expected, cows receiving 
rbST had increased concentrations of serum IGF·I by Hour 
40; this increase elevated serum IGF-I to similar absolute 
levels in GRFi and HSAi cows (Fig. 2). The greater per· 
centage incre-dSC in serum IGF-J observed in GRFi cows re­
ceiving rbST may indicate that GRFi cows are more sensi­
tive to rbST. Alternatively, the observation that {he absolute 
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increase in IGF-J was s imilar in GRFi and HSAi cows may 
indicate that capacity for IGF-I synthesis and secretion is 
not altered by GRFi. Future studies will be required to clar­
ify these possibilities. 
Delayed puberty has been observed in GRFi he ifers in 
association with low serum IGF-I (3, 4] and in plerocercoid­
treated female rats in association with depressed serum ST 
141). In the present study, aCtive immunization against GRF 
lowered FA. concentratiOn') of IGF-J in the DOM and SUB 
follicle . however. magnitude o f difference was not as pro­
nounced as that observed in serum (Figs. 2 and 4). Since 
IGF-I has been proposed as a local regulatOr of ovarian 
funCtion (7, 9], a decrease in FA. IGF-I may also be involved 
in the delay of puberty observed in GRFi heifers. It is equally 
possible that GRFi may decrease ST in m to levels s imilar 
to that observed in serum. On the basis of previous reports 
(43], one would expeCt transudation o f ST from serum to 
FFL Although FFL ST concentration was not measured in 
the current study, our laboratory has demonslrated the 
presence of GRF antibodies in FFl, al Ie\-els > 90% of that 
detected in serum, aspirated from GRFi cows (42J. We 
therefore specutare that ffi ST woukl be correlated to serum 
ST concenlration in the present study. 
DOM taken from cows receiving rbST had greater con­
cenlrations of IGF-I regardless of immunization Status (Fig. 
4). This agrees with studies in gilts in which administration 
of porcine pituitary ST increased FFL and serum IGF-I con­
centrations (22, 24, 25]. Hammond et al. (44] reported that 
an increase in m IGF-I concentration is associated with 
increased fo llicular growth. Additio nally, FFL IGF-I levels 
have been shown to increase with follicular diameter (44, 451, 
and twinning in cattle has been suggested to be associated 
with elevated serum and m IGF-I [46]. Neither a correla­
tion between follicular diameter and IGF-I nor a treatment­
by-diameter interaction was significant in the present study. 
These observations are in contraSt to results in the lite ra­
lure (44- 471, possibly because the majority of follicles ex­
amined in the curren! study would be classified as large 
(2: 8 mOl) follicles. However, Howard and Ford {481 failed 
to demonstrate strong correlations be(\\'(!(!n follicular di­
ameter, estradiOl, and follicular IGF-I in weaned sows. Co­
treatment with ST and gonadotropins for human in vitro 
fertilization and embryo transfer has been shown to in­
crease m IGF-I concentrations, number of oocytes col· 
letted, feni lization rate, and number of oocyres cleaved (491. 
These data collectively support a role for FA. IGF-I in reg­
ulating follicu logenesisj however, conclusive evidence reo 
mains elusive. 
It is important to determine the origin of FA. IGF-1. Fol­
licular IGF-I could o riginate from serum (via transudation), 
and levels observed cou ld be a reflection o f systemiC effects 
(431· This is supported by the Significant correlation be· 
tween serum and FF1. IGF-I concentratio ns obseIVe<i in the 
present study. However, several Studies have shown IGF-I 
to be produced within the ovary of rats (50-521, cows {531, 
pig (91, and humans [541. In addition to the evidence for 
ovarian synthesis of IGF-I, it has been shown that IGF-I se· 
cretion by porcine granulosa cells in vitro is enhanced by 
gonadotropins, estradiol, and ST (11,55], Greater differ­
ences In serum than in m after rbST treaunent be(Ween 
GRFi and HSAi cows in the current study suggest differ­
ential regulation of serum and follicular levels of IGF-I (Figs. 
2 and 4). Spicer et al. (S6] observed that the ratio of FA. to 
plasma IGF-I tended to be greater in foUicies from we (Days 
3-6) than from early (Days 1 or 2) estrus in mares. Fur­
thermore, short-term fasting (48 h) of Hereford x Freslan 
heifers (571 o r feed restriction of cycling cows (42) has been 
reported to significantly decrease plasma IGF-I conceOlra­
tions without affecting IGF-I concentrations in large folli­
cles. These data suggest that under cenain physiologic con­
ditions, IGF-l concentrallons may be regulated locally. 
In the CutreOl study, eCG did not affect fo llicular IGF-I 
or IGFBP-2 concentrations. The lack of an effect may in­
d icate an insufficient eCG dosage resulting from our desire 
to avoid superovulation. However, the eCG used In this srudy 
was shown to be biologically active via increased ovulation 
rate in mice (29]. Concentrations of estradiol and P, in FFt 
could not be detennined because of inadequate sample 
volume. It has been indicated that the ovarian IGF system 
functiOns a~ an imponant local amplification mechanism for 
Steroidogenesis and gonadotropin action [7,58]. Hsu and 
Hammond [11 1 have reported enhanced secretion of im­
munoreacm-e IGF-I by cultured pordoe granulosa cells when 
treated with LH and/or FSH. In 1'9.'0 separate studies, fol · 
licular IGF-I concentrations have been reported to increase 
during eCG-induced follicular growth in gilts {24, 59]. Ada­
shi e t al. (60] have shown the ability of FSH to regulate 
granulosa cell IGFBP in a dose- and time-dependent, but 
biphasic, manner. Studies conduCted in rodents concerning 
the effects of eCG on fo llicular IGF-I are difficult to inter­
pret, as such effects may be species-specific. Spicer et al. 
(45] reported minimal changes in IGF-I levels during spon­
taneous or GnRH-induced follicular development in post­
partum cattle. 
Since IGFBP modulate IGF function, defining how they 
are regulated in the ovary is critical to understanding changes 
in ST-IGF-I physiology. Through immunobloning or FFl, 
three fonns of IGFBP were identified as IGFBP'3, -2, and 
-5. It is most likely that the band migrating at 24000 Mr is 
IGFBP-4, as this IGFBP has also been identified in human 
FFl (61 ). All three fonns were present in FA.. from both 
DOM and SUB follicles . Multiple IGFBP species have been 
reported previously in FFL from murine and human FA. 
(62- 641 and IGFBP-2 through -6 have been detected in por­
cine FFL [651. Immunobloning analysis aJso indicated the 
presence of IGFBP-2 and -5 fragments corresponding in size 
with fragments that have been identified in serum of neo­
natal fasted pigs 166) as well as in media conditioned by pig 
smooth muscle cells {67] and by human fibroblasts 136]. 
Fragment formation of IGFBP-5 in conditioned media of 
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human fibroblasts has been shown to be regulated by JGF­
I. Whelher such a mechanism is operative for any form of 
IGFBP at the level of the ovary remains to be determined. 
In contrast [0 serum ST and IGF-I concentratio ns, cir­
culating IGl-"SP-2 conce ntrations were elevated in GRF-im­
munized cows. This is consislent with observations that 
.serum IGFBP-2 is elevated in humans [68] and in transgenic 
mice [691 with ST deficiency. In the presem study, rbST de­
creased serum IGFBP-2 in cows with normal (HSAi) and 
suppressed (GRFi) serum ST while Simultaneously increa'>­
iog serum IGF-I (Fig. 3). These data suggest that serum ST 
and/or IGF-I are mediators of serum IGFBP-2 concentra­
tions. Treatment with rbST has also been reponed to sig­
nificantly decrease .serum IGFBP-2 in iaaating dairy cows 
[34,70). In COntrast, infusion of IGF-I has been shown to 
induce IGFBP-2 in humans in vivo [71,72]. The mecha­
nism(s) by which e ither ST or IGF-I mediates serum IGFBP­
2 concentrations is presently unknown. 
Concentrations of IGFBP-2 were e levated in both serum 
and FA. from SUB fo llicles o f cows immunized against GRF, 
and treatment with rbST decreased IGFBP-2 in serum as 
well as in FA. from DOM and SUB follicles of both GRFi 
and HSAi cows. Also, average concentratic;>ns of IGFBP-2 were 
greater in FA.. from SUB than in f'FL from OOM follicles or 
in serum. Collectively these data, coupled with the obser­
V'd tion that IGFBP-2 is negatively correlated with follicular 
diameter, indicate that IGFBP-2 is synthesized at a higher 
rate in small follicles. However, all compartments (OOM, 
SUB and serum) may have been affected by changes in serum 
IGFBP-2, because IGFBP-2 decreased in all compartments 
following rbST. In contrast, GRFi increased levels of IGFBP­
2, -5, and ·4 in FA. o f SUB but not DOM, suggesting that 
regulation of these IGFBP in DOM may be occurring locally 
at me tL<;sue level. Ovarian tissue mRNA foc IGPBP-2 mrough 
-5 has been identified in the rat [73,74J, for IGFBP-2 and 
-3 in the pig [751. and for IGFBP- l through -3 in the human 
[76]. Furthermore, cultured granulosa and thee-,ll cells have 
been shown to synthesize IGFBP [76-78,62J. Therefore, 
changes in local producrion of IGFBP have the potential to 
playa key role in regulating the availability of IGF to ovar­
ian cells. Addition of exogenous IGFBP has been shown [ 0 
inhibit the ability of FSH and IGF-I to stimulate steroido­
genesis, cAMP generation, and DNA synthesis in cu ltured 
granulosa cells [12,79,801. Recently, IGF analogues with re­
duced affinities for IGFBP but not the Type-I receptor were 
shown to be mo re effective than IGF-I in enhancing FSH­
stimulated accumulation of P1 by rat granulosa cells [811 
and in stimulating IGfBP synthesis [82]. Since FSH also has 
been shown ' to inhibit the secretion of IGFBP by granulosa 
cells [61,62,77], this may represem a mechanism by which 
IGF availability is increased to promote granulosa cell growth. 
Furthermore, activatio n of Type-I IGF receptors in porcine 
granulosa cells by IGF-I results in increased synthesis and 
release of IGFBP, which, in !Urn, appear to sequester and 
neutralize IGf-1[82]. However, several forms of IGrlW have 
also been shown to .')timulate IGf bioactivity in other cell 
types under cenain conditions 183]. Therefore, the exaa role 
of the IGFBP in modulating IGF ad iviry at the level of the 
ovary in vivo remains unknown. 
GRFi increased the re lative amounts of IGFBP.2, -4, and 
-5, while decreasing the amo unt of IGFBP-3 in ffi from 
OOM and SUB. Nakatini e t al. [73J and Erickson et aL 174J 
have reported IGFBP-4 and ·5 mRNA to be localized almost 
excl usively to granulosa cells of atretic follicles. IGFBP-2, 
-4, and a 29000 Mr IGFBP were also significantly increased 
in FFl. from women with IXlIYCYStiC ovarian disease [61], 
while no difference in IGFBP-3 levels was reported. There­
fore, the V'.trious forms of IGFBP could play different roles 
in regulating follicular groMh. 
It is apparent that ST, IGf-l, and IGFBP are inte rre lated 
in serum and FA. of catlle. The presem study has prOVided 
evidence suggesting that IGF-I and IGFBP are differemially 
regulated in DOM and SUB follicles in cycliC beef cows. 
How these ho rmones participate in attainment of puberty, 
fo lliculogenesis, and ovarian function is not understood, 
panirularly in vivo. Future studies are net..-'ded to clarify how 
interactions between IGF-I and IGF13P affea fo llirular growth. 
ACKNOWLEDGMENTS 
We thank E. Heimer aOO K. Campbell of lloifmann·b Roche, InC Nutley. NJ. for 
providing CRf-{l-29)-(;ly..c;I)'~. Nl-I, conjugated «) hulTWl serum albumin. Appre­
dation is expr~ to C. ILannell of MonsantO Co., St. Louis., MO. for pn:Mdin8 
5On"~'Irlbo>~ (r«:<;ombinam ONA·derived som:uOIropin). Purified O\'ine .'!OmalOiropin 
(S-o. (Wine Sf anti$erum (by AF. P:lrlow, PifUif.3ry 1I0nTlOflel aOO Antiserl Center. 
Torr.lflC<:. CA), and hulTWl in:;ulin·like gro...,h factor I anti.<;erum (by L Underwood 
and JJ. Van Wyk, Chapel Hill . NC) Wl.'tt obtained through the National I lormone 
and Pitu itary Progn.m. NIOOl(, and Univ_ of Maryland. School of Medicine, Ilaltimore, 
MO. App~ion is expressed to Dr. S.P. Washburn, Dr. O.W. Robison. P. Stricker. 
D. A$kew. L Cole. V. Hedgpeth. Il. ~Iuff, C. Kirby. C. Marsh Jr.. and R Sin'pwn for 
their t«hnicaJ assistaf'lCt:. 
REFERENCES 
I. 	Anderson U. Dc\-elopment in Cllves and heifers after h}poph)'Si:llSla]k transec· 
tlon or h}popI1ys<"Ctorny. Am J I'hySiOI 19n; 231:IH97·J:SQj. 
2_ 	 Troul WE. Schanbacher BD. Growth hormone and iruulin·like growth factor.! 
reo;porues in Meers actively immuniZt:d against somatostati n or growth hormone­
releasing factor. J Endocriool 1990; 125: 123- 129. 
3. 	Simpson RB. ArmMr-ong JO. Harvey RW. Miller DC, Heimer EP, Campbell I/,.\\. 
Effea Ofa<.li,-e immunll3lion ag:lin.<;l growth hormone--rc!easing faaor on gr"",h 
and onset of puberty in beef heifers. J Anim Sci 1991; 69A914-4914. 
4_ 	 ArmMrong JD. SWlko RL, COhick WS, Simpson RB. Harvey ](Ill. Huff BG. Clem· 
mons DR. WhilaCre MO, C3mpbcll RM, Ue imcr EP. Endocrine C\',:11IS prior to 
puherty In heifers: role of somatOlTOpln, insulin·like 8ro...1h factor·! and In.,ulin. 
like growth f:lClor binding prOieins. J Ph)'Siol Ph;umaco! 1992; 4jl)uppl 1): !79­
193_ 
5. 	 H~emann J II . Ilammond AC. »au"",n DE, Reynolds 1':1, McCutcheQn SN. Tyrrell 
HF, Haaland GL Effect ofbovitW: growth hormone admini>tr:1lion on metaboH<m 
of growing heifers prolein and lipid ~abolism and plasma con<:entr3llons of 
meubolites and hormones. J Nutr 1986, 116:250<1 -2515. 
6. Clemmons DR. Insulin·like grOl>lh f:Ictor hlnding prOlc:ins: roles In regUlating 
IGF ph~iology. J Dev Ph~ioI 1991 ; 15:105- 110. 
7. 	Mashl EY, Resnick CE. O'Ercole N, Svobo<b ME, Van Wyk D. Insulin ·lIke growth 
factors as intrl<N.lrian regularon; of granul"'" cell grov.1h and funalon_ Endocr 
Rev 19115, 6,400--420. 
8. VcldhuisJD. Rodgers 1\,1. AZimi 1'. CarmcyJ. Juchu:r O. /l-l:Iy W. Meclunisrru wI:>­
scrvlng the :;terQidogenic synergism bc:tweoen follic1e-stlmull!in8 hormone and 
Insul in. loke grOl>lh f:lOor·1 (somalornet!in C): ailL'r:Jtions in cellular ,llero! me­
",bolism in ~winc gr-..nulosa cells.. J Iliol Chern 1967, 262:76S6--~. 
299 SERUM AND FOlLICUlAR IGF-I AND IGFBPs IN CAntE 
9. 	Hammond ]M, Mvndschcin JS. Sanlar:lS 5£. Smith SA. Hagen DR The o--arian 
insulln·like growth f>(.10r s)'stem. J Reprod t'e nil 1991 : 43:199-200­
10. 	ScIwn. O. Lule"..J peptidt::s and illlr"li<;eUuw- corrullunialioo.) Rt:prod Fenil SuppI 
1987; 34:87-99. 
II. 	Hsu G), Hammond ) .\1. Goruulouopiru and C5tradlol j.llmulau: immunore;octi'"e 
lGF·1 productioo br porcino: granulosa cell in _itrQ. fnd<xrinology 1987: 1200198­
207. 
12. Ui M. ShlnlOllka M. Shimasaki S. Ung N. An insulin.like grOMh faoor· binding 
pJ"OIein In ovarian follicular nuld block$ follide.Slimul.:I!inK hormone·stinlulated 
steroid pnXlucrlon by ovariaIl granulosa cells. iOndocrinology 1989; 125:912-916. 
13. 	Uksak TA. Ullg N, Depaolo LV. O'...rian intrabursal admini:$lnti<ln o f insulin .likc 
groo."lh factor-binding prolein inhibitS follicle ruplure in gonadoiropin ·treated 
immature femak rn~•. Bioi Reprod 1991: 44:599--603 ' 
14. i.angho ul D}. Spicer lJ. Geisen RD. Dc."vdopmt:nl 01 a cuilure ~ern for Ixwi~ 
granulO'la cel\:;: efferu of 8ffi""lh hormone. e&radiol. and gonadotropins on cell 
prolifcr:uion, steroiciogcne5is,and pn"llein S)·ntm,sis. J Anim Sci 1991; 69,3321­
33}1. 
15. Ilsu GJ. Hammond JM. Cooronlilant dfeas of groMh hormone on SC<:reJion of 
inso.Jlin·llke WO"1.h factor I and progesterone br cuhun.'d pordnt: granuloo;a cells. 
Endocrinology 19117: 121:1343-IWI. 
J6. Jia X·C. KlI.lmiln], Hsueh A Groo.·th hormone <::nhancn foliid.e-sllmulating hex· 
mone-ioduced dilfenn:iation of culrurt.'<l raJ granulo6:l cells. ErxIocrinology 1966; 
1 J8:1401- 1409. 
17. MCShanc TM. Schillo KK, BolingJA. Hradley NW. tWI JI!. EffectS of recombinant 
DNA-derived sonulOlropin and dietary energy im:oo: on developmt:nl of beef 
heiftTS: I. gl"O"--th and pubcrt).. ] Anlm Sci 1m., 67:2230-2236_ 
lR 	MCShane ThI. Schillo KK, E&ienm:' "U. Bollng]A. Bradley NW, II"II JB. EffectS o f 
re<:ombinam D:-IA-deri,ed somaJotropin and dietary inl3ke on de--elopmem of 
beef heifers: [I. ConcemrnllonS of honnoncs and m<:tabolil¢; in blood se.... J 
Anim Sci 1989; 67:2237-2244. 
19. 	Schemm SR. Deaver DR, Greil LC Jr, Muller In. Effects of reoombinIDl oo..·ine 
SQrnaIOIropin on luJeinizing hormone and ovarian funoion in 10000ing dairy rows. 
Bioi Reprod 1990; 42,815-821. 
20. 	Gong jG, Bramley T, \l:'ebb R The effect of re(:()lllbin:rnt oo..·ine .o;omalOlropin 
on O\--arian function in heifcr.l: follicular popubuiQru; and p'."riph<.'ral hormones 
Bioi Reprod 1991: 45:941-949 . 
21. 	 Rieger D. Walton JS, Goodwin I>U, johnson W1-l. The cffca of Cl)-u.,..ltJnent with 
re.:ombinIDl bovine sormuOIropin on pla5J1la proges!el"OllC concemralion and 
number of embryos coll<.'Ctoo from supcr()\"Ulated Hol5Jcin cows. Tlx."riogc-nol . 
oSy 1991; 35:863-868. 
22. Bry:tIl KA. Hantmond jt.l. Canning S. Morxbht-inJ. Carbough DE, ClarI< A\l, Hagen 
OR Reproductive: and growth reIpOn$t of gillS 10 e xogenous pord~ pilUil3l1' 
1If(Rr,-th hormone_) Anlm Sci 1989; 67, 196--205_ 
23. 	 Bryan KA. Cw-k AM, H:unmond]M, ~n DR Effect of COIl.';llI/lI vcrsus adJUSled 
dose ofexogenous porcine gr<l"--th hormooe (pOH) on w-owth and rcproducrh-e 
maraaeristia; of giltS. ] Anirn Sci 1991: 69:29&l-2987. 
24. 	 Samarn.s SE. Mondst:"ltcinJS, fuyan K, ~n D, Harrunond)M. Grov,~h homlOnt: 
dfeos on O\-...rian function in gillS, changes in Insulln-like groMh factOrs and 
their binding proo:elns. Bioi Reprod 1990: U (suppl 1}126 (abstract 256). 
25_ 	 Spicer 1J, Klindt J. Uuonomo FC, :\\aurer R, Yen rr, F.chlemk:amp SE. Effca 01 
porcine $Om':ll0u0pin on nUnlber of granulosa cdiluJeini7.lng hormone/hUlllan 
chorionic gnnadolropin reccptOJS, OOCI-tC ,·iability. and concentrations of SIC­
n)irus and insulin·like gr<l"--th farn.m; r and II in follicular fluid of lean and obese 
giltS. ] Anim Sci 1992; 7t"l:j119-3157. 
26. 	 Stanko RL. ArITl.Stl"Ol18 JD, JIaNey RW. Helmer EP, Campbell R\l. Effca of feed 
rcsuiction or aal_"C Immunll:lllon ag:alnsI gw..-th Ilormone reieasi"3 f.Ktoc (GRF) 
on serum ill5ulin_like gro<'oth faeroc I ([GF-I), ADG and 00S1eI of puberty in beef 
hcifCT$. J Anim Sd 1992: 7O(suppl 1):.275 (ahslract S45). 
27. Moore KE, ArmstrongJD, Campbell RM, Heimer EP. Effca of acti,.., immunization 
~lnsJ groo.-th hormone releasing faaor 00 roncentr.l1ions of .'iOIT"IatOJropin and 
Insulin-Ilk~ growth faCIor [in lactating bttfoows. Domesl Anim tOndocrinoll992: 
9:125-139. 
28. 	NRC. NutriCflt Requirements of Reef C:utle (tifh ed). Wa<ihing!OO. DC: Natioruo.l 
Academy Press; 1984: 45_ 
29_ 	 Luhritz DL, Eist!n FJ , Robison OW_ Eifca of selecrion for lill",r s ize ~nd body 
weighl on hormone.induced Q\lUl;nIOn raJe in mice. J Anim Sci 1991 : 69:4299­
4305_ 
30. 	Amts!rongjD, Spcu:'!JW. Inllm-'t:nQUS admlnisiraJion <Jf iOfl<.lphores In ruminants: 
effcru on metabolism indepcndt:nl ofthc rumen.) Anim Sci 19fI8; 66: 11rJ7- lgl7. 
31. Housekoo<:ht KL. B<IRgs 01.. Campion DR, Sanin]L, Kher 11:. l!ampacek GB, Amo:s 
HE. Effect ofdietary energy SO<Jn:e and Ie.-el on SCmm growth hormone. Ittsulin _ 
like 81"O""th bctor I, gr()<l,o~h and body compusilion in bed heifers.) Anim Sd 
19ffl: 66:2916-2923_ 
}2 	 Ho lland MD. Hossner KL. Ni5wender GD, Elsasser lll , Odele KG. Validalion of 
a he-teroIogous r.wioimmunoassay fer iosuUn_likt: groo.-th fxIor·( in ~inc serum 
J iOndo<:rinol 1988: 119:281- 285 
33. jones 1;1 , AmIstrong.JD, llarvey RW. Otanges in metaboIilt5, metabolic hormor>CS 
and IUleinlzlng hormone befon: puberty In Angus. llnfocd. Charolais, and Sim· 
me nol heifers. J Anim Sci 1991; 69:1607-1615. 
34. Cohid< \l'S, McGuire MA. Clemmons DR, Bauman UF.. Regul.ltion of lGF-1 bind· 
Ing prolClns in &crum and l)"fnrh of 1:l<:Wlng rows by .""""IOII'OPln. Endocrl · 
nology 1992; 130:150S-1511_ 
35. 	Hosscnlopp P. Seurin D. 5e:go'I'ia·Quln'lOO 13, HardQuln S, Binoux M. Anal)'sis 01 
:iCrum insulin ·llke groo.th factor binding pro:eins using Wt:Stern bloning: use d 
the method foc lilr.uion of 1m, binding pr(J(Cill5 and competidve binding srudies. 
Anal Biocbcrn 1986: 154:138-143_ 
36. 	CamacroHubner C, Busby WHjr, McCusker RH, Wright G. demmons DR. lden· 
tificatlon of lhe fomlS of ill5ulin·like growth boor./)indlng proteins produced 
by human fibroblasis and the m«hanisms that regulJle thcir secretiOn. ] Bioi 
Ole m 1992; 267:11949-11956. 
37. SAS. SAS/SfAT Guide for Personal Compulel"!; (6th cd). Cary, NC: Sfati!ltical Mal­
)'Sis S)":$ICtn InsJitme. tnc. : 1985, 183-260_ 
38. 	AmIstrong./O, f..sbenshade KL. Johnson JL, Coffey "rr, Heimer E, Campbell RM , 
MO.·..les T. fdlK A AcJh.., immunlz:uion of pigs against growth homtone.releas-­
Ing boor.: eifca 00 concel11rations of 8ffi"th hormone and instJlin ·like growth 
f.«:Jor. j Anim Sci 1m 68:427-4'54. 
39_ 	 Armstrong]D, E>bcnshack KL. Coffey MT. Helmer E, campbell R, MD"'les T, Fdlx 
A Opioid control of 8fO"th hormone in the suckled SOW is primaril)" ~diaJed 
through gw.."Ih hormone reIea~ fucror. DorneSI: Anim EndocrinoI 1990; 7:191­
,,. 
40. HaI"\"C)-' RW, Arrrtsuung'/o, Heim....- EP, CimpbelJ RM. feedlOl po:rformwce. 011"­
~ charw:tcrisJics. hormon<'s and meJaboIi!cs In llet:rS a::tively Immuni;:cd ag:oinst 
g""",h hormone releasing faaor. J Anim Sci 1993: 7 J:(in press). 
41. 	 Ramaley]A. Phares CK. Delay of puberty onseJ in females due to s uppres.sion o f 
growth hormone. J:ndocrinolog)' 1980, 106:1989- 1993­
42. Kirby q , MrTlStrong )D. Hulf BG, Strnko RL. Harvey RW, Heimer EP, C:unpbell 
ltM. Ota.oge! in serum .o;omaIOlropin, SOn13lOlropin mR'<A, serum and follicuw­
In~ulin·llke gr<l"--th factor-I in respon~ to f<:«J restriction in rows aai"el)' im· 
mUni7.e(\ against growth honnone releasing factor. J Anim Sci 1993; 713033­
)<)42 
43. 	G<:«Icn 1lG. Humer RHF. Telfer E. Torr:trJa.' C. BI"O"'IT N. Ph)'Siological f.K:tors 
underlying the formation of QI.;u-ian follicular fluid.J Reprod i'enill968: 820813­
'" 44. 	Hammond JM. Barnnao j1$, Skaleris D, Knigtu AB, Romanus JA. Rechler MM. 
Production d insulin-like gro.."lh fuctors by oo.-arian granulosa cells. Endoc:rl· 
nokls"!' 1985; 117:2553- 2555. 
45. Spi~r 1,), Eduernk:atnp Sf, Canning SF. HammoooJM. RelalionShip belwe"" con­
centraJions of immunoreactM: insulin-like gro..lh factor-I in follicular fluid and 
various biochemical n'ari<ers of dlffercrniatlon In oo..·1ne anlral foIlkles. Bioi Re­
prod 1986: 39:573-SSO. 
46. 	 Echternk:atnp SE, Spicer lJ, Gregor)" [(E. Canning Sf. Hammond ]M. Cona'.-mr:l­
~ons of insulin·like growth factor-I in blood and QI.-arian follicular nuid of cattle 
selro<.'d for Iwins. Bioi Reprod 1990; 43:8-14. 
47. Spker lJ. Enrighl~. Conrentr1llions of insulin -like gl"O"--th factor I and sterolrus 
in follicular fluid of preo\"ulaJOl"y bovine QI.'arian follicle<;: dfea 01 daily injee_ 
lions of a grm.th hormone-reJeasing faaor analog and/vr thyrotropin·relosing 
hormone J Anlm Sci 1991 ; 69:1133-1139_ 
48_ 11~'ard IU . Ford.u_Rel.:uionshlp; among COlKCfltr:llioru d steroJds, Inhibln, In _ 
sulin-like growth factor-I (lGF·I). and IGF-bindlng proo:elM during fullicubr de-­
velopmc:nt in wean..-d SO<\'S. Bioi Reprod 1991; 47:193-201. 
49. 	Owen l;J, Shvh:un l. Ma<;on RA. Ostergaard H,~ liS. Coa"e:mtent with gro..-th 
hormone, after piluiJary s uppressioo, ror ~an SlinluLaUon In in vitro feniliza· 
tioo_a randomized. d::ouble-blind. placebo-control trial. Fertil Steril 1991: 5&1104­
1110. 
50. Murphy [J , Bell G[, Friesen IIG. Tiss"'" distribution of insulin_like gro..-th bctor 
I and [] messenger ribonucleic add In the adu~ rat. Endocrinologl' 1987; 120:1279­
1282. 
51 . Hemandc"l ER, Roberts O·Jr. Lt:rOlh 0 , Adashi 1:"0'. R'll ",""rian insuUn·like growth 
factor I (lGF·1) gene expression Is granulosa cell-selectl_"e' 5' -unnmslat..d rnRNA 
variam repr.,;en(3lion and hormonal regulation. EndocrInoIClg)' 1989: 1Z5:572­
574. 
52_ OlkerJE, Altman "I). Powell JF, Wilson CIt. Cbytoo RN. Insulin_like sro"'~h fooor 
1gene expres.~ion in the r~t QI.... r")· 1s ronfined to lite granulosa celis of develop. 
Ing follkles. Endocrinology 1989: IH:2671- 2<i79. 
53. 	&htcrnkantp SI;. Spicer 1J. Mrthem biOI ana\J"Sis ol i"",,Un-like gro..th factor­
I mRNA tn bovine granulosa cells. J Anim ScI 1991; 69(suppJ 1):07 (ab6!r:>a 
165). 
300 	 STANKO ET A.L 
Si. VOUI,blnen R, Millet Wl Coord'nat(' tropic hormone regulalioo or mR.'IAs for 
insuInlike gror."Ih boor 11 and !he dloIe5teroI sicJe.chain~ en>:)'TTIe 1'450­
in human 5I~ 1is5ues. Proc lUI Aad SCi ]987; 84:IS90-I~. 
55. 	Hsu C-}, Hammond 1M. COncomitant eff«u of 8fO"UI ~ on .secTetion 01 
Irw.JIin-Ih groo.'lh £:aaor.' :.n:I progesIerOfIC by a>kumI pon:ne ~ cd1$. 
Endocrinology 1987: 121:J}4)- 1l48. 
56. 	Spicer y , nx:tcer ICE, Htnderson KA, Ouby lIT. ~ of insulin-like 
growth bcror· ' In 10111(\11# nuld and bbxI pbsma of mares wong <:3r1y :and 
blc 0QIru5. AIllm Rcprod ScI 1991: 2'5:57-65. 
57. Spicer IJ, C~ M.... Prend/viJIe OJ, Goulding D, Enright \1'). ~Ic boo: not 
Il'IIl"3OI'aI"ian COI'II:eIlIf1Illon:! of insuli ... ~ growth bctor·, arc affcaed by shon­
lam mciflg. Bioi Rcprod 1992: -'6:920-925. 
S8. 	 HammondJ.'1 , MondscheinJS, Samaras SE, Canning SF. The ~ insulin·like 
IIfO"o'Ih beton, • loail :lmplifiCltion rn«hanism for $(eroidogencsis aoo hor· 
mone action. J S«.'I'Oid Blochem Mol Bioi 1991 : 40:411 - 416. 
59. 	H:lITImondJM, /Isu Cl, Klindt J. TWIg Bt\. Downey BR. GonlIdOI:ropin.s I~ 
coneentr.ulons of Immuoorl"Xt~ Insulln.like gr0'001h factor [ in pordne follic­
ulat nuld In vivo. Bioi Reprod 1988; 38:304- 308. 
60. Adashl EY, Resnick CE, Hurwitz A. Ricdarelli E, HcrlWlde~ ER, Roo:!nfeld RG. 
o...ri2rlgl';l/'lulooa ccJl-<krl"ed Insulin-like 1VO"1h bctoc birxling proldns: mod· 
uwary role cI folJIcie-admumlng hormono::. Endocrinology 1991; 128:1*760. 
61. 	~ GAS, M;IfI<lfflll DA.. Insu lin·like gr00l.1h factor binding p~ins in ll"3l"ian 
follicles from women wilh poI)'CyS1lc 1MlI"W1 d~llular source and level. 
11'1 follicular nuiIJ. J Oin Endocrinol & Metab 1992; 7S;IOJO-IOI6. 
62. Adashl £Y. Ranlck CEo 1Iem;tnde1. Ell, Hurwitz A. Rosenfeld JIG. CWarian gran­
uw ~U-deffled l!l.'Iiulln·!ike g~ bdor (IGF) binding pfOle;ns-re~ d 
low molecular ..-eIghI. hlgh4lfllli'Y IGF·5eIeor."e spo:dcs. 1>,0] Cell Endocriool 
1990; 7-'=175- 1&1. 
Ii). 	MondscheinJS, Elhenoo ro. IbmmondJM. ~ dinsulin-like gror.th 
baor-bin:li'll pmeim dporctne 0IWUn 'JIliolbr Ouid. BioIItepnxII991. #JIS­
64. Guldia:"" lC. In$ulln·like grov.th bctor$ and (lv.lIrian follicular de>-eIopment. En· 
doo" Rev 1992; 13~1-669. 
6S. 	Shlm~ S. Gao t. ShilJl()llab M. Ung N. IsobDoo and mokcubr ,~ d 
illSUJin.like growth baor-bindins protein-6. Mol Endocrinoklgy 1991 ; 5:9~9'8. 
66. 	McCusker lUI . COhick \lIS, Husby WIt Clernm()n$ OR EvalWlion of the devd· 
QpmeJlCiI and nuU"ilionaJ ~ in pordne illSUlin·like gro.mh baor·blndlng 
promn·1 and Pl'OIein·Z !lerum Jev.cls by immu~. Endocrinology 1991; 
129:2631- 263(1. 
67. Cohick \lIS. Gockennan A. Clemmom Olt V~lar $rTIOOth mU$(Le <:ells $)'lIme,. 
slze!WO forms d Insulin· like growth flICloc binding proceill$ (IGFBP) whidl ar" 
regulaled diff~!Jy by the IGF:s. j Cell ~ioI 1993; 157:52-60. 
68. Hardouln S, Gourmdeo M, Nogulo. P, Seurin 0 , RogIuni M. I.e IkIu<: Y, f'ovQ;I 
G. Merlmee 1), Hos.senlopp 1'. Binowr M. Mol«ular forms of ~rum inwlln·like 
groMh factor ( IGF}blndlng pr(l(e lns In man: rela!!onship with gr!)\O,th hormone 
;I(l(i IGFs and ph)"SIoIogiclI 5ignlflc2nc.-. J Clln Endocrinol & Meub 1969; 69:1291­
1301. 
69. ~Ilubner C. Ocnmons DR. D1'lcoIc~. JquUOOn of ;n,;u\in.LiIu: 8'O"m 
baor b1ndiog procetns In u-ansgcnic mic"e "ith altered ~ d growth 
hormone and IGF--I. EnUocrinoIom· 1991 ; 129:1201 - 1206. 
70. Vicini Jl., Buonomo fC, Veenhulzeln .D. Miller MA. Ocmmons DR. COllin" R.I. 
Efl"C'Cti d nlJ!rilional babnc"e and Mage 01 blution in dairy rows on irooUn, 
insulin.likc: growth f.Ictors 1 and II and insulin ·11ke glU'!o1h factor b1flditl1: prore;n 
2 responses 10 soma!ouopln admlni$trallon. J NUll" 1991; IZ1:1656-1664. 
71. ¥ J. Sdwnid C. GuIer lIP. JI.qp.II:U:ln d~ pnlIrin; b imuli....like groy.m 
baors in humans: increM«l cxpreMion d IGF b1ndmi! proldm during U"ellll' 
mmt of healthy llduks and In palienls ..."idl ~ rumor. J Clin Im= 
1990; 86:952- 961. 
72. You.ng SQ, U!ldo:rwood U;, Cc:lnikcr A. Clcrnrn()rl$ OR Effeas 01 reoombilWll 
Imulln·mce gro..th baor-I ( !GF·!) and growIh ~ on serum IGf·blnding 
prolelns In (";I1or1c-~lIy mlric1ed ~dulIS.J Oi" t:ndocriool & Meub 1992: 7S;6(\}­
""­
73. N-.lk:llanl A. Shlma&lkl S, Erickson GF. Ung N. Tissue·:specifk expression 01 four 
1~lin·likc: growth f~·binding Pr(l(eill!! (I, 2,}, and 4) in !he rat (.Mr)". En· 
docrlnology 1991; 129:152 ' - 1529. 
74. 	Eridoon GF, NalClllanl A, IJng N, Shlnusald S. Localization 01 i~lIfl. lil«: grQ'Mh 
factor.bindlng pr(l(eln·5 me5.'ienger ribonucleic acid in ra! (Mlries during !he 
~rous cycle. l' ruJo.;;rinology 1992; 130:1867-1878. 
75. 	Samaras Sil. Jt.agen 011. Shlmasaki S, Ung N. Harnmond)M. ExpressIon ol ill$uli .... 
like grov.1h fac:1or-bindlng pl"Ol"in·Z and ·3 ~r ribonucleic acid In !he 
porcine ovary: locali7.a!ion and physiologicol changes. Endocrinology 1992, 
130:273~274<1. 
76. Gludic"e LC. Milld M. 1>lllkovo-,;ld DA. D:anasouri D. 1IWJW1 granulosa rontaIn 
~ ribonucleic adds f;"nl"I)ding insuli....like growth bctor-binding: pro. 
! .. ins (IG~"BI'5) and seaell' IGFBP5 in culm ..... FeniL Steril 1991: 'j():-t~. 
n. Mondsd"'inJS, Smith M, HarnmondJM. ProdUdion 01 insulin·like ItfO""'lh boor 
binding pl"Olc:ins ( IG~'8Ps) by pordne gnnuJos:o cells: lden!iflcllllion d IGFBp·2 
and ·3 and rquiallon by hormones and gI"OI'Ith OOQB. Endocrinology 19'»; 
127:2298-2306. 
78. 	Sullclwi A.plbnenj. Koistinen It.. HUIl(lW II. RiM)5 0 , R:Inla T. So:ppb M. HlJJlWl 
gr:anulow. cdl!; i)T'Ilhe!iize bot molecular "''Cigh! insulin-I ..... grovolb baor-bind· 
Ing prolein. Endocrinology 1989; 12HMS-l090. 
79. 	8ics1k TA. Shhnonw. M, Matk090.·sld M, Ling N. Insulin·1Jke gro..1h factor-binding 
protein (lCF.BI') inhibl!ion of granukl&a cell funaion--dko on q.:Uc ;odroQ. 
.w.c }'S~. ~ acid S}TlIhesis. Mld ~ ....id\ 
t~ dl"ect d an IGH antibody. EndocrInology 1990; 126-.21&1-2189. 
80. Shimasal<i S, Shlmonalo M. Ul M, ~ S, Shibata F, U", K Structural char. 
KtefiZllllIOll of a folilcle--sdmullllling hormone acrion inhibi!or in porcine ovariarI 
IQIllrular auld-Its idcfItifl(2ioo a5 the Insulin· like growth factor·blndi"8 pro­
!eln, J Bioi Chem 1990; 265:2196-2202. 
81 . AdashII:."Y. Intt"aQ'.':ItUn pt:pddes-51.imulatorl; and inhibi!0C5 of follicular g:fOI'1h 
and differentlal!on, Ilndocrinol Mt."cob Clin Nonh Am 1992; 21 :1-17. 
82. 	Grimes RW, Hammond JM. InsuUn and In:;ulin·like groy.1h facrOf$ (lG ~·s) Slim· 
ulatc: production of IGF·bindlng proldns by O\'3rian granu]O$lI cells. Endocri· 
nology 1992; 131:553 -558. 
83. Clemmons OR. IGI' binding pr(l(dns_ rt-gul3!ion of reUutar aaions. GlU"th Re­
8u1 1992; 2:80-87. 
